Continue to site >
Trending ETFs

Name

As of

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

Vitals

YTD Return

N/A

1 yr return

33.6%

3 Yr Avg Return

21.2%

5 Yr Avg Return

19.9%

Net Assets

$455 M

Holdings in Top 10

29.7%

52 WEEK LOW AND HIGH

N/A
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 1.00%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 88.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

$0

IRA

N/A


Fund Classification

Fund Type

Open End Mutual Fund


Name

As of

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

IEHSX - Profile

Distributions

  • YTD Total Return N/A
  • 3 Yr Annualized Total Return 21.2%
  • 5 Yr Annualized Total Return 19.9%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.39%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    VY BlackRock Health Sciences Opportunities Portfolio
  • Fund Family Name
    Voya
  • Inception Date
    May 03, 2004
  • Shares Outstanding
    N/A
  • Share Class
    S
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Erin Xie

Fund Description


IEHSX - Performance

Return Ranking - Trailing

Period IEHSX Return Category Return Low Category Return High Rank in Category (%)
YTD N/A -50.0% 268.1% N/A
1 Yr 33.6% -64.8% 268.1% N/A
3 Yr 21.2%* -100.0% 115.6% N/A
5 Yr 19.9%* -100.0% 58.6% N/A
10 Yr 9.8%* -12.1% 26.2% N/A

* Annualized

Return Ranking - Calendar

Period IEHSX Return Category Return Low Category Return High Rank in Category (%)
2023 N/A -100.0% 73.0% N/A
2022 N/A -76.0% 212.6% N/A
2021 N/A -65.0% 900.0% N/A
2020 N/A -87.3% 336.8% N/A
2019 N/A -60.1% 304.1% N/A

Total Return Ranking - Trailing

Period IEHSX Return Category Return Low Category Return High Rank in Category (%)
YTD N/A -50.0% 268.1% N/A
1 Yr 33.6% -64.8% 268.1% N/A
3 Yr 21.2%* -100.0% 115.6% N/A
5 Yr 19.9%* -100.0% 58.6% N/A
10 Yr 9.8%* -12.1% 26.3% N/A

* Annualized

Total Return Ranking - Calendar

Period IEHSX Return Category Return Low Category Return High Rank in Category (%)
2023 N/A -100.0% 76.6% N/A
2022 N/A -30.7% 212.6% N/A
2021 N/A -65.0% 900.0% N/A
2020 N/A -87.3% 341.1% N/A
2019 N/A -60.1% 304.1% N/A

IEHSX - Holdings

Concentration Analysis

IEHSX Category Low Category High IEHSX % Rank
Net Assets 455 M 10 804 B N/A
Number of Holdings 120 1 17333 N/A
Net Assets in Top 10 136 M -7.11 B 145 B N/A
Weighting of Top 10 29.65% 0.0% 20474.3% N/A

Top 10 Holdings

  1. Johnson & Johnson 3.99%
  2. Biogen Idec Inc 3.82%
  3. Pfizer Inc 3.46%
  4. Merck & Co Inc 3.19%
  5. AbbVie Inc 3.02%
  6. Alexion Pharmaceuticals Inc 2.58%
  7. Bayer AG 2.55%
  8. Celgene Corp 2.49%
  9. UnitedHealth Group Inc 2.34%
  10. Covidien PLC 2.22%

Asset Allocation

Weighting Return Low Return High IEHSX % Rank
Stocks
90.07% -142.98% 259.25% N/A
Other
6.93% -7288.76% 493.15% N/A
Cash
3.00% -2458.20% 7388.76% N/A
Preferred Stocks
0.00% -21.20% 80.89% N/A
Convertible Bonds
0.00% -0.37% 144.58% N/A
Bonds
0.00% -955.59% 2458.15% N/A

Stock Sector Breakdown

Weighting Return Low Return High IEHSX % Rank
Healthcare
88.29% -15.38% 100.00% N/A
Technology
1.01% -26.81% 99.57% N/A
Basic Materials
0.49% -5.18% 96.19% N/A
Consumer Cyclical
0.27% -20.80% 87.44% N/A
Utilities
0.00% -3.80% 94.95% N/A
Real Estate
0.00% -8.52% 100.26% N/A
Industrials
0.00% -19.53% 93.31% N/A
Financial Services
0.00% -7.59% 99.69% N/A
Energy
0.00% -6.25% 144.83% N/A
Communication Services
0.00% -9.27% 90.02% N/A
Consumer Defense
0.00% -7.54% 98.24% N/A

Stock Geographic Breakdown

Weighting Return Low Return High IEHSX % Rank
US
76.33% -142.98% 149.27% N/A
Non US
13.74% -38.73% 159.65% N/A

IEHSX - Expenses

Operational Fees

IEHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.00% -2.86% 950.64% N/A
Management Fee 0.75% 0.00% 2.87% N/A
12b-1 Fee 0.25% 0.00% 1.00% N/A
Administrative Fee 0.10% 0.00% 52000.00% N/A

Sales Fees

IEHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 25.00% N/A
Deferred Load N/A 0.25% 5.50% N/A

Trading Fees

IEHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 0.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

IEHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 88.00% 0.00% 5067.00% N/A

IEHSX - Distributions

Dividend Yield Analysis

IEHSX Category Low Category High IEHSX % Rank
Dividend Yield 0.00% 0.00% 84.51% N/A

Dividend Distribution Analysis

IEHSX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Monthly Annually

Net Income Ratio Analysis

IEHSX Category Low Category High IEHSX % Rank
Net Income Ratio 0.39% -46.00% 10.88% N/A

Capital Gain Distribution Analysis

IEHSX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

Distributions History

View More +

IEHSX - Fund Manager Analysis

Managers

Erin Xie


Start Date

Tenure

Tenure Rank

May 01, 2011

3.17

3.2%

Xie is the managing director and Portfolio Manager of BlackRock Advisor. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.

Thomas P. Callan


Start Date

Tenure

Tenure Rank

May 01, 2011

3.17

3.2%

Thomas P. Callan, CFA, Managing Director and senior portfolio manager, is head of BlackRock's Global Opportunities equity team. He oversees the team's investment process, leads the team's Investment Strategy Group, and provides portfolio and risk management oversight for all of the team's products. In addition, Mr. Callan is a member of BlackRock's Leadership Committee. Mr. Callan's service with the firm dates back to 1988, including his years with PNC Asset Management Group, which was integrated with BlackRock in 1998. He started as a health care analyst for PNC's mutual fund group and later served as an international equity analyst. Mr. Callan began his investment career at PNC Bank as a personal trust portfolio manager in 1988. Mr. Callan earned a BA degree in economics, with honors, from Boston College in 1981.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.01 33.52 5.37 3.25